Coventry University Featured PhD Programmes
University of Kent Featured PhD Programmes
Ulster University Featured PhD Programmes
CoSector, University of London Featured PhD Programmes
University College London Featured PhD Programmes
10 miles

University of Hull, Hull York Medical School Molecular Biology PhD Projects, Programs & Scholarships

We have 11 University of Hull, Hull York Medical School Molecular Biology PhD Projects, Programs & Scholarships

  • Molecular Biology×
  • University of Hull
  • Hull York Medical School×
  • clear all
Order by 
Showing 1 to 10 of 11
  Applying Population-Level Microbiota Resistance Profiling in Skin Wounds
  Dr A Oates, Prof M Hardman, Mr G Smith
Application Deadline: 29 January 2020

Funding Type

PhD Type

This PhD project is based in Hull York Medical School. Antimicrobial resistance is recognised as a major global health and economic threat.
  How does the vascular matrix environment influence platelet activation?
  Dr S Calaminus
Application Deadline: 31 March 2020

Funding Type

PhD Type

The platelet is a blood cell that plays a key role in the prevention of bleeding. For platelets to form a clot or thrombus effectively, they must rearrange their actin cytoskeleton to withstand high shear stress from blood flow in the arteries.
  Identification of novel glucose-dependent alterations responsible for vascular dysfunction in Type 2 diabetes.
  Prof Tim Palmer, Dr R Sturmey
Application Deadline: 31 March 2020

Funding Type

PhD Type

Diabetes is a growing global healthcare problem. The majority of people living with diabetes have Type 2 diabetes mellitus (T2DM), characterised by a resistance of the body to the action of insulin.
  Innovative Bioinformatics Pipeline Development for Microbiota Analysis
  Dr D H Lunt, Dr A Oates, Prof M Hardman
Application Deadline: 29 January 2020

Funding Type

PhD Type

Recent advances in metagenomics, particularly long-read sequencing, are delivering a wealth of new and detailed community level profiling data.
  Modulation of platelet-mediated innate immune responses in chronic lymphocytic leukaemia
  Dr M Arman
Application Deadline: 31 March 2020

Funding Type

PhD Type

Chronic lymphocytic leukaemia (CLL) is the most common form of leukaemia in the Western World. B-cell receptor-induced intracellular signals are critical for the survival of leukaemia cells and disruption of this pathway by the Bruton’s tyrosine kinase (Btk) inhibitor ibrutinib is a highly effective CLL therapy.
  Precision-cut lung slices to investigate the effect of human rhinovirus on cough and airway inflammation
  Dr L Sadofsky
Application Deadline: 31 March 2020

Funding Type

PhD Type

The human Rhinovirus (RV) is the major cause of the common cold. There are no current treatments or vaccines for the virus other than over the counter preparations to alleviate symptoms.
  Re-purposing diabetes medicines to manage bleeding complications in myeloproliferative neoplasms.
  Prof Tim Palmer, Dr D Allsup
Application Deadline: 31 March 2020

Funding Type

PhD Type

Myeloproliferative neoplasms (MPNs) are a group of three related blood cancers in which the bone marrow overproduces one of the three cellular components of blood (erythrocytes, leukocytes and platelets).
  Supporting Healthy Microbiota in Aged Skin
  Prof M Hardman, Dr A Oates
Application Deadline: 29 January 2020

Funding Type

PhD Type

This PhD project is based in Hull York Medical School. The skin is home to diverse communities of microorganisms that display elaborate topographical variation.
  Targeting chronic inflammation to improve vein graft function following bypass surgery.
  Prof Tim Palmer, Prof M Loubani
Applications accepted all year round

Funding Type

PhD Type

Targeting chronic inflammation to improve vein graft function following bypass surgery. Coronary heart disease (CHD) causes over 66,000 deaths/year in the UK.
  The Role of CCR5 in Embryo Development
  Dr R Sturmey
Applications accepted all year round

Funding Type

PhD Type

Chemokines are small peptides that play key roles in cell migration and signalling. They act primarily by binding specific cell surface receptors to drive intracellular signalling and are key mediators of the immune response.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2020
All rights reserved.